Patent ID: 7867503
Filing Date: 2011-01-11
Classification: A61K,A61P,C07K

Abstract:
1. A method for treatment of a disease or condition associated with presence of Toxoplasma gondii in an individual, the method comprising: administering to the individual a therapeutically effective amount of a chimeric recombinant antigen to a subject in need thereof, wherein the chimeric recombinant antigen contains a chimeric fusion of at least three different antigenic fragments of wherein said antigenic fragments are B-cell epitopes which bind to wherein the at least three different antigenic fragments have an amino acid sequence selected from the group consisting of: SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 8, SEQ ID NO: 10, and SEQ ID NO: 12.